This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Explore various ways to make money in just one week. With dedication, you can boost your income quickly and efficiently.
25,170 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Analysts say the United States holds roughly $45 trillion in natural resources, a cushion that could delay debt press...
Solana marks a major milestone as the Alpenglow consensus upgrade starts on a test cluster, with co-founder Anatoly Y...
Bitcoin could be poised for further weakness if historical midterm-year patterns repeat, with analysts flagging a pot...
Goldman Sachs raises Enphase Energy's price target to 57 and maintains a Buy rating, highlighting a nascent rebound i...
As AI accelerates, the stock narrative centers on NVIDIA, AMD, and Broadcom. This guide breaks down why each could de...
Ripple faced renewed selling on May 28 as major tokens breached supports, pushing the ripple (xrp) price down and sig...
When a cybersecurity stock slides, it tests your risk tolerance and judgment. This guide breaks down what happened wi...
Meta's AI forecast points to a near-term Bitcoin dip followed by a multi-week rally as ETF flows and policy catalysts...
CrowdStrike shares declined about 9% after a fiscal Q1 beat that failed to meet loftier expectations, triggering a br...
POET Technologies has logged a 220% surge over the past year, but traders are contending with signs of a potential co...
Shiba (SHIB) has entered a difficult period, with prices down roughly 65% over the past year and on-chain activity co...